Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucogen in nasopharyngeal carcinoma
NCT05780294Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of Leucogen in myelosuppression, sponsored by Sun Yat-sen University. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
Leucogen
03
Conditions
myelosuppression
Beyond the preview
Go deeper on NCT05780294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05780294.